Gain Confidence In Clinical Trial Outcomes

Source: Thermo Fisher Scientific

Recent guidance from the US Department of Health and Human Services Food and Drug Administration on enrichment strategies for clinical trials encourages the use of smart packaging technologies as a tool to more accurately understand a patient’s exposure to the study drug. This recent guidance, along with increasing encouragement by regulatory agencies to better measure medication adherence, elevates the opportunity to leverage smart packaging and devices to enrich clinical trials.

Integrating smart packaging solutions into clinical trial strategies can improve medication adherence to dosing protocols and provide a comprehensive understanding of a patient’s exposure to the study drug.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Supply Leader? Subscribe today.

Subscribe to Clinical Supply Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Supply Leader